Literature DB >> 34140096

The Interplay Between Nutrition, Metabolic, and Endocrine Disorders in Chronic Kidney Disease.

Tala Mahmoud1, Lea Borgi2.   

Abstract

The kidneys are responsible for maintaining our bodies' homeostasis through excretion, biodegradation, and synthesis of different hormones. Therefore, a decline in renal function often results in significant derangements in hormone levels. The most common metabolic and endocrine abnormalities seen in patients with chronic kidney disease include deficiencies in erythropoietin, calcitriol, triiodothyronine, testosterone, and estrogen. In addition, accumulation of hormones such as adiponectin, leptin, triglycerides, and prolactin also is seen. Subsequently, this can lead to the development of a wide range of clinical consequences including but not limited to anemia, hyperparathyroidism, insulin resistance, anorexia-cachexia, infertility, bone disorders, and cardiovascular diseases. These disorders can negatively affect the prognosis and quality of life of patients with chronic kidney disease, and, thus, early diagnosis, nutritional intervention, and pharmacologic treatment is imperative.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic kidney disease; endocrine disorders; metabolic disorders; nutrition

Mesh:

Substances:

Year:  2021        PMID: 34140096     DOI: 10.1016/j.semnephrol.2021.03.012

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  3 in total

1.  Mechanisms of Cardiorenal Protection With SGLT2 Inhibitors in Patients With T2DM Based on Network Pharmacology.

Authors:  Anzhu Wang; Zhendong Li; Sun Zhuo; Feng Gao; Hongwei Zhang; Zhibo Zhang; Gaocan Ren; Xiaochang Ma
Journal:  Front Cardiovasc Med       Date:  2022-05-23

Review 2.  Low Testosterone Level and Risk of Adverse Clinical Events among Male Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Cohort Studies.

Authors:  Li Li; Huixiang Ju; Hao Jin; Hongmei Chen; Mingzhong Sun; Zhongwei Zhou
Journal:  J Healthc Eng       Date:  2022-09-10       Impact factor: 3.822

Review 3.  Interconnection between Cardiac Cachexia and Heart Failure-Protective Role of Cardiac Obesity.

Authors:  María Elena Soto; Israel Pérez-Torres; María Esther Rubio-Ruiz; Linaloe Manzano-Pech; Verónica Guarner-Lans
Journal:  Cells       Date:  2022-03-18       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.